These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30990148)

  • 21. Prognostic impacts of diabetes status and lipoprotein(a) levels in patients with ST-segment elevation myocardial infarction: a prospective cohort study.
    Li N; Zhou J; Chen R; Zhao X; Li J; Zhou P; Liu C; Chen Y; Wang Y; Song L; Yan S; Zhao H; Yan H
    Cardiovasc Diabetol; 2023 Jun; 22(1):151. PubMed ID: 37365608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-dimer level predicts in-hospital adverse outcomes after primary PCI for ST-segment elevation myocardial infarction.
    Huang D; Gao W; Wu R; Zhong X; Qian J; Ge J
    Int J Cardiol; 2020 Apr; 305():1-4. PubMed ID: 32057475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of thrombus burden on short- and long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Köktürk U; Somuncu MU; Uygur B; Akgül Ö; Püşüroğlu H
    Coron Artery Dis; 2022 Nov; 33(7):559-565. PubMed ID: 35942618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Caused by Ectatic Infarct Related Arteries.
    Bogana Shanmugam V; Psaltis PJ; T L Wong D; T Meredith I; Malaiapan Y; Ahmar W
    Heart Lung Circ; 2017 Oct; 26(10):1059-1068. PubMed ID: 28216061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between electrical myocardial instability and postinfarction remodeling in patients with ST-segment elevation myocardial infarction.
    Oleynikov VE; Barmenkova YA; Dushina EV; Golubeva AV
    Kardiologiia; 2021 Oct; 61(10):14-25. PubMed ID: 34763635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study).
    Ertelt K; Brener SJ; Mehran R; Ben-Yehuda O; McAndrew T; Stone GW
    Am J Cardiol; 2017 Jun; 119(12):1917-1923. PubMed ID: 28427734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary artery ectasia, an independent predictor of no-reflow after primary PCI for ST-elevation myocardial infarction.
    Schram HCF; Hemradj VV; Hermanides RS; Kedhi E; Ottervanger JP;
    Int J Cardiol; 2018 Aug; 265():12-17. PubMed ID: 29731349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Not Available].
    Luboyatnikova ES; Kiselev AR; Komarova MV; Rodionova VA; Kapp EV; Duplyakov DV
    Kardiologiia; 2018 Dec; 58(12):5-12. PubMed ID: 30625091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Wang Z; Ren L; Liu N; Lei L; Ye H; Peng J
    Kardiol Pol; 2016; 74(10):1160-1166. PubMed ID: 27160177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deferred versus conventional stent implantation in patients with acute ST-segment elevation myocardial infarction: An updated meta-analysis of 10 studies.
    Lee JM; Rhee TM; Chang H; Ahn C; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Hahn JY
    Int J Cardiol; 2017 Mar; 230():509-517. PubMed ID: 28057364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
    Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Post primary percutaneous coronary intervention no-reflow in patients with acute myocardial infarction: contributing factors and long-term prognostic impact].
    Han YL; Deng J; Jing QM; Wang SL; Ma YY; Luan B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):483-6. PubMed ID: 16842659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The impact of admission blood glucose level on the prognosis of ST-segment elevation myocardial infarction].
    Liu Y; Yang YM; Zhu J; Tan HQ; Liang Y; Liu LS; Li Y
    Zhonghua Nei Ke Za Zhi; 2009 Jun; 48(6):465-8. PubMed ID: 19954040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.
    Zhao L; Zhu W; Zhang X; He D; Guo C
    BMC Cardiovasc Disord; 2017 Jan; 17(1):16. PubMed ID: 28061808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of sex difference in clinical presentation (stable coronary artery disease vs unstable angina pectoris or non-ST-elevation myocardial infarction vs ST-elevation myocardial infarction) on 2-year outcomes in patients undergoing percutaneous coronary intervention.
    Tang XF; Song Y; Xu JJ; Ma YL; Zhang JH; Yao Y; He C; Wang HH; Jiang P; Jiang L; Liu R; Gao Z; Zhao XY; Qiao SB; Xu B; Yang YJ; Gao RL; Yuan JQ
    J Interv Cardiol; 2018 Feb; 31(1):5-14. PubMed ID: 29023996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarction.
    Zhang Q; Shen J; Zhang RY; Qiu JP; Lu JD; Zhang Y; Chen YH; Zhang JF; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Chin Med J (Engl); 2007 Nov; 120(21):1862-7. PubMed ID: 18067756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Jensen LO; Maeng M; Thayssen P; Tilsted HH; Terkelsen CJ; Kaltoft A; Lassen JF; Hansen KN; Ravkilde J; Christiansen EH; Madsen M; Sørensen HT; Thuesen L
    Am J Cardiol; 2012 Mar; 109(5):629-35. PubMed ID: 22152969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-year clinical outcomes of ST segment elevation myocardial infarction patients treated with emergent percutaneous coronary intervention: the impact of thrombus burden.
    Tungsubutra W; Towashiraporn K; Tresukosol D; Chotinaiwattrakul C; Phankingthongkum R; Wongpraparut N; Panchavinnin P
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S139-46. PubMed ID: 24772591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
    Pres D; Gasior M; Strojek K; Gierlotka M; Hawranek M; Lekston A; Wilczek K; Tajstra M; Gumprecht J; Poloński L
    Kardiol Pol; 2010 Jul; 68(7):743-51. PubMed ID: 20648428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.